版本:
中国

BRIEF-Argentum Pharmaceuticals, Allergan settle patent dispute over Restasis

April 18 Allergan Plc

* Argentum PHARMACEUTICALS and Allergan settle patent dispute over Restasis

* Argentum Pharmaceuticals - specific date on which Argentum may launch generic product and other details concerning settlement have not been disclosed

* Argentum Pharmaceuticals- agreement generally provides Argentum may commence marketing generic equivalent product sometime prior to expiration of patents covering Restasis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐